ARCHIVES

Patents: Myriad Patents Spectrometry To Assess DNA Polymorphisms

This article is from The Cancer Letter archive.

Vol. 25 No. 09 | March 5, 1999

Download PDF Visit The Full Archive

Related Articles

Breast Cancer Coalition Widens Its Agenda For Advocacy, Vows To Fight NIH Cutbacks

May 5, 1995

NCI Programs: Seven Win Awards For Cancer Genetics Network, Informatics

July 31, 1998

Drugs and Targets: Akynzeo approved for chemotherapy-related nausea

October 10, 2014

New Treatment Approaches for Leukemias Emerging From Early Clinical Trials

December 31, 2004

EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure.

March 2, 2007

NCI Begins Phase III Trial Of Shark Cartilage In NSCLC.

May 25, 2001